Effect of supplementation in treatment of women with polycystic ovary syndrome

Phase 3

• Conditions: Polycystic ovary syndrome.; Sclerocystic ovary syndrome Stein-Leventhal syndrome; E28.2

• Registration Number: IRCT201508025623N49
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Women aged 18-40 years
Patients with PCOS according to Rotterdam criteria

Exclusion Criteria

Hyperprolactinaemia
Diabetes mellitus (DM)
Thyroid disease
Subjects following a special diet or consuming drugs with an effect onhormonal profile like oral conceptives (OCP), ovulation induction agents and anti-obesity therapies in the last 3 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation.